Skip to content

Oral low dose Amiodarone and prevention of atrial fibrillation

The effects of oral low dose amiodarone in prevention of atrial fibrillation after coronary artery bypass graft (A Placebo-Controlled Randomized Clinical Trial)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201207303799N4
Enrollment
170
Registered
2013-05-04
Start date
2012-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Diseases. Atherosclerotic heart disease

Interventions

Intervention 1: In the intervention group with systolic blood pressure above 80 mmgh and rate of more than 60/min, a total of 4.2 grams oral amiodarone is administered as: 600 mg, the night before sur
Prevention
In the intervention group with systolic blood pressure above 80 mmgh and rate of more than 60/min, a total of 4.2 grams oral amiodarone is administered as: 600 mg, the night before surgery and also 60

Sponsors

Tehran University of Medical Sciences Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with coronary artery disease (on angiography) who are candidate for coronary artery bypass. Exclusion criteria: 1- Patients above 80 years old. 2- Patients who have atrial fibrillation before surgery. 3- Patients with heart valve disease or arrhythmia or having every degree of heart block conduction. 4- Patients who use a pacemaker. 5- Patients who have chronic lung, liver or kidney disease. 6- Patients who have other heart surgeries simultaneously with bypass surgery. 7- Patients who are allergic to amiodarone or in any way giving amiodarone to them is contraindicated. 8- Having sick sinus syndrome.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
AF rhythm. Timepoint: From the second day of the intervention and after CABG surgery, continuous monitoring for the first 72 hours and then daily ECG is done until discharge. Method of measurement: ECG recording device.;Length of stay in ICU. Timepoint: At the time of transferring to the ward. Method of measurement: Refer to the data sheet in ICU.;Duration of hospital stay. Timepoint: At discharge time. Method of measurement: Refer to the Patient file.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasim Shayan

Cardiac Surgery and Transplantation Research Center of Dr. Shariati Hospital

ctrc@tums.ac.ir; nsm_shayan@yahoo.com+98 21 8863 3037

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026